The 4Ts is a pretest clinical scoring system for heparin-induced thrombocytopenia (HIT). Though widely used in clinical practice, its predictive value for HIT in diverse settings and patient populations is unknown. We performed a systematic review and meta-analysis to estimate the predictive value of the 4Ts in patients with suspected HIT. We searched PubMed, Cochrane Database, and ISI Web of Science for studies that included patients with suspected HIT, who were evaluated by both the 4Ts and a reference standard against which the 4Ts could be compared. Quality of eligible studies was assessed by QUADAS-2 criteria. Thirteen studies, collectively involving 3068 patients, fulfilled eligibility criteria.
Introduction
Heparin-induced thrombocytopenia (HIT) is a prothrombotic and potentially fatal adverse drug reaction mediated by platelet activating antibodies against multimolecular complexes of platelet factor 4 (PF4) and heparin. 1, 2 Management involves cessation of heparin, avoidance or postponement of an oral vitamin K antagonist until platelet count recovery, and initiation of a non-heparin anticoagulant. [3] [4] [5] Accurate diagnosis and prompt commencement of therapy are paramount. Delays in treatment are associated with an initial 5-10% daily risk of thrombosis, amputation, or death. 6 Misdiagnosis of HIT, conversely, may result in exposure of thrombocytopenic patients to alternative anticoagulants and their attendant ~1%
daily risk of major hemorrhage 7, 8 or in thrombosis from unnecessary suspension of heparin. 9 The diagnosis of HIT, which rests on both clinical assessment and laboratory testing, remains challenging despite these high stakes. Clinical evaluation is complex and imprecise, even among experienced diagnosticians. 10 Laboratory tests for HIT are of two varieties. Widely available immunoassays are sensitive and simple to perform, but yield frequent false-positive results. 11 Washed platelet functional assays such as the 14 C-serotonin release assay (SRA) have much greater specificity, but require radioisotope and reactive donor platelets, reagents that are unfeasible for most clinical laboratories. 12 Consequently, such assays are available to the majority of clinicians only as "send-out" tests and do not yield results in a timeframe necessary to inform initial clinical decision-making.
The 4Ts (Table 1) is a pretest scoring system for HIT that was developed to improve and standardize clinical diagnosis. It incorporates four typical features of HIT: (1) magnitude of Thrombocytopenia; (2) Timing of thrombocytopenia with respect to heparin exposure; (3) Thrombosis or other sequelae of HIT;
and (4) likelihood of oTher causes of thrombocytopenia. The system yields an integer score between 0 and 8 with scores of 0 to 3, 4 to 5, and 6 to 8 classified as low, intermediate, and high pretest probability for HIT, respectively. 13, 14 The 4Ts is widely used in clinical practice and a number of single center
For personal use only. on July 15, 2017 . by guest www.bloodjournal.org From experiences with the model have been reported. However, the generalizability of these studies to other settings and patient populations is uncertain. The objective of this systematic review and meta-analysis was to estimate the predictive value of the 4Ts in a heterogeneous group of patients with suspected HIT.
Materials and Methods

Data sources and searches
We performed a systematic review of the literature to examine best evidence for the predictive value of 
Study Selection
Articles were examined by one reviewer (AC), first by title and abstract, then by review of the complete paper as indicated. Additional articles were sought through review of bibliographies. Studies of patients with suspected HIT, who were evaluated by both the 4Ts and a reference standard (defined subsequently) against which the 4Ts could be compared, were eligible for inclusion. Studies were excluded if the reference standard was an immunoassay, owing to the limited specificity of such tests.
11,12
Data extraction and quality assessment Key characteristics were extracted from eligible studies and recorded in an evidence table by one reviewer (AC). These included: author, year of publication, study design, characteristics of study participants (patient population, age, and gender), setting, reference standard, disease prevalence, and number of subjects found to be positive and negative for HIT relative to the reference standard in each 4Ts probability category. Information was requested from authors when it was not included in the published report. Two reviewers (AC, TEW) independently evaluated study quality using QUADAS-2,
15
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Data synthesis and analysis
The principal summary measures of our meta-analysis were the positive predictive value (PPV) of a high (score ≥ 6), intermediate (4 to 5), and combined high and intermediate (≥ 4) probability 4Ts score and the negative predictive value (NPV) of a low probability score (≤ 3). Predictive values, sensitivities, specificities, and corresponding 95% confidence intervals were tabulated for each 4Ts probability category in each study. The binomial-normal model for meta-analysis of proportions 16 was used to determine pooled estimates of these measures. Subgroup analyses assumed a different binomial proportion for the two strata. Proc NLMIXED from SAS/STAT software version 9.3 (SAS, Cary, NC) was used for all analyses. A p-value less than 0.05 was considered statistically significant.
To explore heterogeneity among studies, we prespecified several sub-analyses. First, because predictive values are known to be influenced by disease prevalence, 16 we compared the performance of the 4Ts in studies with a low (≤0.10) and high (>0.10) prevalence of HIT. We used 0.10 as the cut-point for this analysis because it represented the median prevalence among eligible studies. Second, we hypothesized that the 4Ts would show better predictive value when performed by study personnel trained and practiced in use of the model than when conducted by referring clinicians. To test this hypothesis, we compared studies that used these two scoring methods. Third, patient population (e.g. cardiovascular surgery, medical) is known to influence the accuracy of HIT diagnostic tests. 4 We planned a subgroup analysis to examine the effect of this variable on predictive value of the 4Ts. Lastly, several eligible studies used a version of the 4Ts that differed slightly from the standard model shown in 
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Results
Study selection
The initial literature search yielded 67 articles. One additional reference was identified from the bibliographies. Fifty-six articles were excluded: 4 were duplicates, 11 enrolled patients without suspected HIT, 10 did not report 4Ts scores, 10 did not define a reference standard or did not apply the standard to all subjects, 13 were reviews, and 8 were case reports. Twelve articles met selection criteria, one of 
Study characteristics
Study characteristics are summarized in The reference standard for defining HIT also differed among studies. One study used a clinical standard, 10 10 studies used a laboratory standard, 14, [18] [19] [20] [21] [23] [24] [25] [26] and 2 studies employed a standard incorporating both clinical and laboratory criteria. 17, 22 The reference standard included a functional assay in all but one of the studies, 10 but choice of assay, methodology, cut-off, and interpretation of assay results varied (Table 2 ).
Several iterations of the 4Ts have been published. Ten of the 13 studies applied the standard 4Ts model shown in Table 1. 14 Patients in one study 17 were scored using an earlier rendering of the model. 13 Scores in 2 other studies were calculated using the Greifswald modification of the 4Ts. 14 The 3 versions of the 4Ts are essentially identical with respect to the "Thrombosis or other sequelae" and "Other causes of thrombocytopenia" categories, but have different criteria related to platelet nadir and timing of platelet count fall.
Study quality
Assessment of study quality by QUADAS-2 criteria 15 raised several potential methodological limitations (Table 3 ). For instance, 4Ts scoring in ten studies was performed by study personnel, often through retrospective chart review. Because this approach differs from anticipated use of the 4Ts in patient care
(scoring by referring physicians through bedside evaluation), concern about the applicability of such studies to clinical practice was judged to be high. Two studies did not state whether 4Ts scorers were blinded to the reference standard. Since awareness of the result of the reference standard could bias scoring, these studies were deemed to carry an unclear risk of bias in this domain. Table 4 shows the number of patients with and without HIT (relative to the reference standard) in each 4Ts probability category. Of 3068 total patients, 1712 (55.8%) were classified by 4Ts score as having a low probability, 1103 (36.0%) as having an intermediate probability, and 253 (8.2%) as having a high probability of HIT. 
Predictive value of the 4Ts
Analysis of heterogeneity
Visual inspection of Forest plots ( Figure 2 ) revealed largely overlapping 95% confidence intervals, suggesting reasonable homogeneity among studies. To further evaluate heterogeneity, we performed several sub-analyses. First, using a cut-off of 0.10, the median prevalence among eligible studies, we compared studies with a high (>0.10, n=5) and low (≤0.10, n=8) prevalence of HIT. The pooled random effects estimates of prevalence were 0.23 (0.13-0.37) and 0.07 (0.06-0.09) in the high and low prevalence studies, respectively. As expected, PPV increased with increasing prevalence. PPV was significantly higher in the high prevalence studies than in the low prevalence studies for intermediate probability Studies were also compared on the basis of whether scoring was performed by study personnel (n=10) or referring clinician (n=3). In one study, approximately 80% of subjects were scored by the referring clinician; 21 this study was included in the referring clinician subgroup. The random effects pooled estimate of PPV was greater in the study personnel subgroup than in the referring clinician subgroup for We planned a third analysis to evaluate the predictive value of the 4Ts in different patient populations.
Because studies did not routinely report patient level data on patient population, we used study level data (Table 2 ) for the analysis. We compared studies with a relatively large proportion of cardiovascular (CV) surgery patients (>0.20, n=8) with those in which CV surgery patients comprised a smaller fraction of the overall study population (≤0.20, n=4). We chose 0.20 as a cut-point because it served as a natural divide among eligible studies. In 4 studies, the proportion of CV surgery patients was 0.18 or less; in the remaining studies, the proportion was 0.36 or greater (Table 2) . One study 20 did not collect information on patient population and was excluded from the analysis. The overall proportion of CV surgery patients in the high and low CV surgery groups was 0.54 and 0.09, respectively. The NPV of a low probability 4Ts Lastly, we conducted a post hoc sensitivity analysis of the 10 studies that used the standard 4Ts scoring system shown in Table 1 were similar to our overall results. The NPV of a low probability 4Ts score remained high after exclusion of studies that did not use the standard 4Ts model (0.995, 0.954-0.999).
Discussion
In our systematic review and meta-analysis of the predictive value of the 4Ts, a low probability score (≤ 3) was associated with a high NPV for HIT (0.998, 95% CI 0.970-1.000) (Figure 2d Consistent with the pooled estimate of HIT prevalence in our meta-analysis (0.11, 0.07-0.17), recent cohort studies suggest that only 7 to 12% of patients referred for laboratory testing in clinical practice have a positive functional assay. [27] [28] [29] A substantial fraction of the remaining, functional assay-negative patients receive "empiric" treatment for HIT. In one single institution study, 35% of patients ultimately determined to have a negative SRA were treated with a parenteral direct thrombin inhibitor (pDTI) prior to return of laboratory results. 10 In another series, only 10% of pDTI recipients had a positive SRA. 7 In centers where functional assays are not available and clinicians must rely on less specific immunoassays, misdiagnosis and over-treatment are likely to be even more frequent. Overuse of pDTIs carries potential adverse medical and economic consequences. These drugs are associated with a 1% incidence rate of major bleeding per treatment day, 8 a risk compounded by the absence of reversal agents, and are approximately 100-fold more costly than an equivalent course of unfractionated heparin. 30 Our findings suggest that the 4Ts score may be used to direct the initial evaluation and management of patients with suspected HIT and to curtail over-testing and over-treatment. In light of the high NPV of the 1 1 model, we propose that it may be possible to exclude HIT and continue heparin in patients with a low probability 4Ts score without need for HIT laboratory testing or treatment ( Figure 3 ). Given that 55.8% of patients in the studies included in our meta-analysis had a low probability 4Ts score, it is likely that implementation of such a decision rule would effect a major reduction in testing and unnecessary treatment. In patients with an intermediate or high probability score, we propose withdrawal of heparin, initiation of an alternative anticoagulant, and acquisition of HIT laboratory testing (Figure 3 ). In view of the modest PPV of the 4Ts, a substantial number of patients without true HIT will still undergo testing and treatment by this approach, underscoring the need for better diagnostic tools. 4 A concern raised by our proposed algorithm (Figure 3 ) is the possibility of missing patients with true HIT despite a low probability 4Ts score. Reassuringly, our findings suggest that such patients are rare. The point estimate of the NPV of a low probability 4Ts score was 0.98 or greater in all but one of the included studies ( Figure 2d ). In this study, 25 For personal use only. on July 15, 2017. by guest www.bloodjournal.org From Several limitations of our study deserve mention. Most meta-analyses of diagnostic tests use sensitivity and specificity as the principal summary measures. 33 To enhance the meaningfulness of our results to clinicians who evaluate and care for patients with suspected HIT, we elected to base our analysis on predictive values, which more fully reflect the clinical utility of a test within a given patient population 16 and may be more intuitive to physicians. 34, 35 A limitation of predictive values is their dependence on disease prevalence. 16 To address this limitation, we performed sub-analyses of studies with a low (≤ 0.10) and high (> 0.10) prevalence of HIT. As expected, PPV was greater in the high prevalence studies. The NPV of a low probability 4Ts score, however, remained high in both groups, suggesting the utility of the 4Ts as a rule-out test for HIT irrespective of disease prevalence. This remained true when different prevalence cut-points were used in the analysis.
Another limitation of our meta-analysis is lack of a uniform reference standard. There is no universally accepted gold standard for the diagnosis of HIT. Functional laboratory assays such as the SRA are considered to have the greatest accuracy among HIT diagnostic tests, 3,4 but lack standardization. 36 Eligible studies in our meta-analysis employed a diversity of reference standards (Table 2 ) and test methods, an important potential source of heterogeneity. Reassuringly, the NPV of a low probability 4Ts score remained high, regardless of the reference standard (Figure 2d ). We consider HIT to be a clinicopathologic diagnosis and recommend that future studies of the 4Ts employ a reference standard that combines rigorous laboratory (e.g. a washed platelet functional assay) and clinical (e.g. expert adjudication) criteria.
Finally, limitations in inter-rater agreement with the 4Ts have been observed with kappa coefficients ranging between 0.5 and 0.7. 10,37,38 Inter-rater agreement was assessed in only one eligible study 10 and therefore could not be addressed in our meta-analysis, but is an important potential shortcoming of the 4Ts that merits further investigation. Newer scoring models, including a revised version of the 4Ts, include more detailed and explicit itemization of clinical features in an attempt to clarify their meaning
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From and enhance reproducibility among raters. 10, 39 In clinical practice, scoring is likely to be performed by the referring clinician (rather than by study personnel). The high NPV of the 4Ts was maintained in studies that employed this approach (0.992, 0.982-0.997), supporting its potential utility in patient care.
In conclusion, our findings suggest that a low probability 4Ts score is a robust means of excluding HIT.
Integration of assessment by the 4Ts in the evaluation and initial management of patients with suspected HIT (Figure 3 ) may reduce over-testing, over-diagnosis, and over-treatment of this disorder. This approach requires investigation in a randomized comparison with intuition-based diagnosis. To overcome limitations of prior studies, such a trial should incorporate use of a single version of the 4Ts, scoring by clinical provider rather than study personnel, and use of a rigorous clinicopathologic reference standard. The 4Ts score is the sum of the values for each of the 4 categories. Scores of 1-3, 4-5, and 6-8 are considered to correspond to a low, intermediate, and high probability of heparin-induced thrombocytopenia, respectively. (Germany)  9  33  11  128  0  55  Pouplard 2007  8  2  14  115  0  74  Bryant 2008  4  8  5  87  0  142  Denys 2008  6  3  4  58  0  31  Bakchoul 2009  26  28  9  121  0  316  Crowther 2010  1  0  1  8  0  39  Cuker 2010  2  3  5  21  0  19  Berry 2011  6  8  9  23  5  53  Nellen 2011  39  35  50  308  7  852  Tawfik 2011  3  5  2  24  0  16  Demma 2011  5  0  6  13  0  19  Total  128  125  148  955  13  1699 HIT, heparin-induced thrombocytopenia; pos, positive; neg, negative Negative predictive value of a low probability 4Ts score Figure 3 For personal use only. on July 15, 2017. by guest www.bloodjournal.org From
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